ZYBERNO
Stock Report
Updated Aug 26, 2026

MOOLEC SCIENCE SA (MLECW)

Consumer Staples • NASDAQ

$0.02

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
12.0/100
POOR BUSINESS
MOOLEC SCIENCE SA (MLECW) scores 12/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-475.7%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

MOOLEC SCIENCE SA (MLECW) stock report — Zyberno Score 12/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.02
Market Cap:$649.65K

Valuation Multiples (2)

P/B Ratio:0.10x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$4.74M

Price Action & Momentum (1)

% of 52-Week High:10.6%
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:-0.6%
Fundamental Growth Rate (g):2.6%

Margin Analysis (1)

Ebitda Margin:-213.4%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.69x
Quick Ratio:1.09x
Cash Ratio:0.66x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-13.62x
Times Interest Earned:-13.62

Capital Structure (4)

Working Capital:5,598,107.00
Cash And Cash Equivalents:5,389,928.00
Long Term Debt:$0.00
Net Debt:-$5.39M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$4.20M
Cost Of Revenue Ttm:$4.86M

Profitability Breakdown (2)

-$659.60K-$9.04M

Bottom Line Performance (3)

-$7.31M
Income Before Tax:$0.00
Ebitda Ttm:-8,964,685.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:0.00
Sga Expense:0.00
Income Tax Expense:$280.89K
Interest Expense:664,020.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:0.0%
Ebitda Margin:-213.4%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$34.79M
Current Assets:$13.75M
Ppe Net:1,142,082.00
Goodwill:281,034.00
Intangible Assets:$8.98M

Liability Structure (4)

Total Liabilities:27,971,164.00
Current Liabilities:8,150,317.00
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$6.82M
Retained Earnings:$0.00
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:808,795.00
Inventory:4,844,773.00
Accounts Payable:3,414,686.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$9.33M-$9.44M

Investment Activities (1)

Investing Cash Flow:-$358.60K

Financing Activities (3)

Financing Cash Flow:-$127.44K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$0.19

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.11
Operating Cash Flow Per Share:-$0.24

Book Value & Capital (2)

Book Value Per Share:$0.18
Cash Per Share:0.14

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.12x
Working Capital Turnover Ttm:0.75x

Receivables Management (2)

Receivables Turnover Ttm:5.19x
Days Sales Outstanding Ttm:70.29

Inventory Management (2)

Inventory Turnover Ttm:1.00x
Days Inventory Outstanding Ttm:363.89

Payables & Cash Cycle (2)

Days Payable Outstanding:256.48
Cash Conversion Cycle:177.70
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:-0.6%
Fundamental Growth Rate (g):2.6%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:MLECW
Company Name:MOOLEC SCIENCE SA
Sector:Consumer Staples
Industry:Food and Kindred Products
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:38.44M
Shares Outstanding Basic:0
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-26 22:18:50 UTC
Data Timestamp:2026-08-26T22:18:50.494057
Scroll to Top